MSFT vs ZENA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
ZENA exhibits severe financial instability, highlighted by a weak Piotroski F-Score of 3/9 and a negative Price/Book ratio of -10.42, indicating negative shareholders' equity. While revenue growth is astronomical at 1225%, it has failed to translate into profitability, with operating margins at -110.49% and consistent, massive earnings misses. The current price of $2.09 trades at a significant premium to the growth-based intrinsic value of $0.28. Overall, the company shows signs of a high-growth venture that is burning cash rapidly without a clear path to sustainable earnings.
Compare Another Pair
Related Comparisons
MSFT vs ZENA: Head-to-Head Comparison
This page compares Microsoft Corporation (MSFT) and ZenaTech, Inc. (ZENA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.